There are two main types of research study: quantitative and qualitative (though some studies use a mixture of these methods).
Quantitative research deals with numbers and measurement and will usually use statistical analysis to draw conclusions. There are two main types of quantitative research: Randomised Controlled Trials (RCTs) and various kinds of trials using observational data (sometimes called population or cohort studies). The section below explains the differences between these two types of study, and their strengths and weaknesses.
The results of quantitative research are often quoted as the Relative Risk which means how much more common it is for a problem to occur in one group than another. In some types of research, particularly population studies (see below) you will see a similar measure called the Odds Ratio. However, for someone trying to decide about a treatment or medical intervention it is often more useful to look at the Absolute Risk. This is the chance of a problem occurring, usually expressed as one in 100, one in 1000 etc.
Qualitative research involves exploring people’s opinions, experiences and preferences in depth, usually through interviews, group discussions or questionnaires.
This article is mainly about the use and limitations of different types of quantitative research study.
Most of the evidence that is used to make recommendations about maternity care comes from quantitative research. This gives us evidence to compare the outcomes from different medical interventions or approaches to maternity care. Unfortunately, evidence is often not clear-cut or may be lacking altogether, and sometimes the research that has been done is of poor quality.
In thinking about what research evidence can tell us, it’s also important to keep the following limitations in mind.
In any kind of research, grouping people together according to one characteristic, such as age, BMI or the fact that they conceived through IVF, ignores the fact that there could be important differences between the individuals in a group. For example, pregnancy and birth outcomes might be very different for someone over 40 who has a healthy lifestyle, is completely well and has had a straightforward pregnancy, compared to one who has existing health problems, or who smokes or drinks heavily, yet recommendations may be made based purely on their age.
Selective reporting, in other words the failure to publish the results of some studies, may be due to Journals only accepting articles about research which have interesting findings or those which support the status quo.
Another issue is what authors choose to report from their research. They may decide not to publish at all, or only report the findings they wanted to prove, or only report some of the outcomes that they measured. Sometimes, if the study did not show the results the researchers were hoping it would, they will pick on some other finding to report, even if that wasn’t an original aim of the study, or claim that there was “a trend towards” a finding even if it was not statistically significant (see below). It is often necessary to dig into the detail of a study to see whether the headline results are supported by the evidence or not.
Quantitative research usually only looks at outcomes that can be measured in the short term. Occasionally there will be follow-up studies that seek to understand the long-term consequences of a medical intervention, but these are the exception. This means that we often don’t know about all the risks, as those that arise after the study ends will not have been recorded.
Studies are only able to focus on a small number of outcomes, so may not be able to provide information about other risks and benefits which you would want to know about when making a decision. This is partly because of practical considerations, but also because if you include a very large number of outcomes in a study it makes the conclusions less reliable, as it much more likely that something will be found that is a chance finding, but not a real effect.
Only rarely do the researchers carrying out a clinical study ask how the people receiving the care felt about it. Even when they do, the information is usually limited to something that can be quantified, such as asking ‘how satisfied’ they were with the care.
The kind of research that is usually considered to be the ’gold standard’ is a Randomised Controlled Trial (RCT). This is where a group of people is randomly divided into two or more groups, each of which receives a different treatment or type of care. The fact that the allocation into groups is random helps to ensure that the groups contain a similar mix of people. That way any difference in outcomes is likely to be due to the treatment or care received, rather than to the groups including more or fewer people with certain characteristics.
RCTs can work very well if it is a case of comparing something like the effectiveness of two drugs but are more problematic when researching something as complex as pregnancy and labour. There are also limitations on how reliable the findings of any RCT can be, as discussed below.
As a result of these problems it is often the case that too few large and well-conducted RCTs have been done to allow any meaningful conclusions to be drawn about what care is best. In some cases, no good studies have been done at all.
The findings of even the best RCT will be limited to answering a specific question about a particular treatment for a particular group of people (and often in a particular healthcare setting such as a hospital). It won’t be able to tell us everything that we might want to know about that treatment for other people or in other settings, or where additional factors are involved.
Each of the groups in an RCT receives a different treatment, so that the outcomes can be compared. Ideally, such trials would be ’blinded’ which means that neither the person nor those conducting the trial know which group an individual is in.
The problem with RCTs looking at care in pregnancy and labour is that blinding isn’t possible. Knowing which group a pregnant woman or person is in may affect both their level of anxiety (which itself can affect the outcomes) and the behaviour of their doctors and midwives, resulting in unconscious bias. For example, a doctor may believe that waiting for labour to start is riskier than inducing it after a set number of weeks of pregnancy. If they are caring for a mother who has waited for her labour to begin, the doctor may want to intervene if they notice signs that they would not normally be a cause for concern. This could affect the frequency of unnecessary caesareans and assisted births. This and other issues are discussed in the article “Routine induction of labour at 41 weeks gestation: nonsensus consensus”1
The results of an RCT can also be misleading if the study was carried out in a way that made it biased. For example, there might be important differences between the groups if
Cross-over is where high numbers of people ended up having the opposite treatment or care to the one they were intended to have. Some cross-over in RCT is expected. For example, in an RCT on planned caesareans it's very likely that some women allocated to a planned caesarean will go into labour before it can be done, and some who are in the planned vaginal birth group will decide to have a caesarean because a concern has arisen before their labour started. For the results to remain valid this cross-over needs to remain low.
In research on induction of labour it is quite common for a high proportion of those allocated to the expectant management (waiting for labour) group to have their labours induced because they have reached a pre-set deadline for the birth to take place or there is a concern over their or their baby's well-being. Similarly, some of those allocated to the induction group may go into labour before the induction is started. This can reduce the reliability of the findings.
It is often not possible to recruit a large enough sample to be able to measure a difference in outcomes. For example, to detect a difference in very rare occurrences such as stillbirth it has been estimated that it would be necessary to include between 16,000 and 30,000 pregnancies in the trial, and this is not usually possible in practice.2
One way around the problem of recruiting a large enough sample is a ’meta-analysis', a type of review which combines the data from multiple studies and uses statistical methods to analyse it. Effectively, a group of studies are analysed as if they were all part of one big study, but there are problems with this approach.
A meta-analysis can only be as good as the trials that go into it, and the results can vary according to which trials the authors choose to include. It is also difficult for a meta-analysis to compare the results of RCTs if they were carried out in different ways or using different methods, or if some important outcomes were not reported in all the studies.
The authors of such reviews will usually comment on the quality of the studies that they have selected for inclusion, and on the overall quality of the evidence available. The typical rating is High/Moderate/Low/Very Low where ‘High’ means that the authors are very confident of having detected a real effect and ‘Very Low’ means they are not at all confident.3
One of the best-known sources of meta-analyses for all kinds of medical questions is the global Cochrane network. Their approach is explained here www.cochrane.org/about-us .
These are studies which observe how the outcomes in real life situations differ between groups defined by one or more characteristics or by a difference in the treatment that they receive. They are also sometimes called cohort studies. There is no random allocation of people to the different groups in this type of study, so they are usually considered to provide poorer quality evidence than an RCT. Nevertheless, they can provide useful information, especially on subjects where large, good-quality RCTs are lacking.
Mostly these are retrospective studies which look back at the records of a population, often over a period of years, and try to identify whether there were certain groups who were more likely than others to experience a given outcome. Alternatively, the investigators may look at how outcomes differed before and after a change in standard care procedures or else compare outcomes according to differences in characteristics such as age or the presence of a health condition.
There are also prospective studies which define the groups to be studied at the start of the research and then follow up what happens to those who fall within these groups, for example, those that do and don’t have their labours induced.
The advantages of this type of study are that they can often involve larger samples than RCTs are able to recruit, and they are looking at what happened in real life. In some cases, especially where it would be impractical or unethical to do an RCT they may provide the only evidence we have.
The disadvantages are that the records that are used are often incomplete, and because there is no randomisation there could be important differences between the groups or in the ways in which their labours were managed which are often not identified but could have a major impact on the results.
Studies can report their findings in different ways, but the authors should always use some sort of statistical analysis to check the probability that their results reflect a real difference. If it is highly unlikely that the finding occurred by chance, this is usually described as being a “statistically significant” result. Note that this is a technical use of the word “significant”. It is not saying anything about the relevance or importance of the finding.
Most medical studies use a significance level of 5%. This means that there’s a 95% chance that the finding is real, but still a 5% chance that it is not real. Another way to look at this is that there is a one in 20 chance that a result found by a study is not a real effect, so a recommendation that is based on just one result in one study may not be reliable.
It is usual to report the 95% confidence intervals for a research finding. This tells you the range of values within which there is a 95% chance that the true value lies. In other words, if an RCT finds that something is 2.5 times more common in one situation than in another, it might report this Relative Risk (RR) as RR 2.5 (95%CI 1.6 to 3.2). That means that the most likely value for the RR is 2.5, and there is a 95% chance that the true value lies between 1.6 and 3.2. However, there is a 5% chance that the true value is higher or lower than these limits (in fact a 2.5% chance that the RR is less than 1.6, and a 2.5% chance that it is greater than 3.2). This means we can be fairly confident that the outcome being measured really is more common in the one situation than in the other.
If both the upper and lower confidence intervals are less than one, then this also indicates that the result is statistically significant, but that there is a reduction rather than an increase in the risk.
For a result to be statistically significant both figures must be greater than one or both less than one. This indicates that it is likely that the study has identified a real effect. If the lower number is less than one (which implies that the effect is to reduce the risk) and the upper figure is greater than one (which implies that it increases the risk) the result is not statistically significant. The study does not show the whether the risk is reduced or increased in one situation compared to the other.
When the numbers number in the confidence interval are very different, this is referred to as having a wide confidence interval. This means we can be confident that there is an effect, but not very sure how big the effect is. We can still say what the most likely value is, but the true increase in risk could be anything from almost none and to many times higher.
Sometimes when a study did not produce the result that was expected (or hoped for) authors may make more of non-significant results than they should. The sort of phrases to watch out for are things like “there was a trend towards x” or “the findings were borderline significant” or “there was an increased/decreased chance of x, but this did not achieve significance”. What all these phrases mean is that we don’t know whether the effect is real or not, and there is a high chance that the effect was not a real, because the finding was not statistically significant.
Research papers, especially if they are likely to have a major impact on clinical practice, will often be ‘critiqued’ by other experts in the field. This means reviewing the strengths and limitations of the research and deciding whether the conclusions can be relied on. A critique of an RCT will usually include analysis of things like:
If you want to get a feel for how reliable a piece of research is, it is worth looking to see whether a critique has been published. Examples of this include “Routine induction of labour at 41 weeks: nonsensus consensus”1 and “Parsing the ARRIVE Trial: Should First-Time Parents Be Routinely Induced at 39 Weeks?”4
An example of tools to use if you want to try critiquing different types of research yourself can be found here casp-uk.net/casp-tools-checklists
Written by: Nadia Higson
Reviewed by: Debbie Chippington Derrick
Review on: 25/03/2020
Next review needed: 25/03/2022
AIMS supports all maternity service users to navigate the system as it exists, and campaigns for a system which truly meets the needs of all. AIMS does not give medical advice, but instead we focus on helping women to find the information that they need to make informed decisions about what is right for them, and support them to have their decisions respected by their health care providers. The AIMS Helpline volunteers will be happy to provide further information and support. Please email firstname.lastname@example.org or ring 0300 365 0663.
AIMS Journal, 2020, Vol 32, No 4 Lorna Tinsley Interview by Rachel Boldero AIMS believes that an effective Nursing and Midwifery Council (NMC) is crucial for a well-funct…Read more
AIMS Journal, 2020, Vol 32, No 4 By Wendy Jones PhD MRPharmS MBE ‘ Scientific, evidence-led information which is very up to date and relevant, and … better informed than…Read more
AIMS Journal, 2020, Vol 32, No 4 The OBS facilitators: Charlotte Gilman, Julie Gallegos, Lisa Mansour and Jayne Joyce (left to right) By Jayne Joyce IBCLC Project Lead Ox…Read more
POSTPONED FROM JUNE 2020 Making a difference past and future The purpose of the day is to celebrate what Birth Activists in general and AIMS in particular have achieved,…Read more
AIMS has submitted comments on the draft update of the NICE Neonatal Infection Guideline. You can read our comments here . The details of the draft guidelines can be foun…Read more
In many parts of the country, there is now momentum building in favour of the implementation of a relational model of maternity care. This is something that AIMS has been…Read more
AIMS has submitted comments on the draft update of the NICE Caesarean Section Guideline You can read our comments here The details of the draft and update schedule can be…Read more